176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.79%
Net income growth under 50% of AVGO's 18.69%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
4.20%
Some D&A expansion while AVGO is negative at -3.72%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
88.65%
Deferred tax of 88.65% while AVGO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
20.22%
SBC growth while AVGO is negative at -3.37%. John Neff would see competitor possibly controlling share issuance more tightly.
-539.35%
Both reduce yoy usage, with AVGO at -18.33%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
34.99%
AR growth is negative or stable vs. AVGO's 169.96%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
4.07%
Some inventory rise while AVGO is negative at -15.65%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-6.70%
Both negative yoy AP, with AVGO at -1035.48%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-841.00%
Both reduce yoy usage, with AVGO at -128.90%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-152.63%
Both negative yoy, with AVGO at -75.72%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-43.36%
Negative yoy CFO while AVGO is 4.27%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-20.77%
Both yoy lines negative, with AVGO at -36.47%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-3960.00%
Negative yoy acquisition while AVGO stands at 97.78%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-41.10%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
12.58%
Proceeds from sales/maturities above 1.5x AVGO's 4.71%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-440.00%
We reduce yoy other investing while AVGO is 2133.33%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-75.21%
We reduce yoy invests while AVGO stands at 125.81%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
79.78%
Debt repayment at 75-90% of AVGO's 100.00%. Bill Ackman urges more debt clearance to match competitor’s lower leverage.
7350.00%
We slightly raise equity while AVGO is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-19.95%
We cut yoy buybacks while AVGO is 45.53%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.